Biogen Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Biogen Inc in the first quarter 2026?
Biogen Inc achieved a return on average equity (ROE) of 7.54 % in its first quarter 2026, which is below Biogen Inc 's average return on equity, which stands at 20.53%.

ROE has advanced compared to 7.28% in the fourth quarter 2025, due to net income growth.

Within the Biotechnology & Pharmaceuticals industry 12 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the fourth quarter 2025 from 235 to 1687.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Equity Change	9.85 %	9.22 %	11.3 %	10.98 %	-
Y / Y Net Income Change	32.85 %	-	20.08 %	8.77 %	-38.87 %
Net Income (TTM) in Millions	1,372	1,293	1,609	1,531	1,479
Return On Equity (TTM)	7.54 %	7.28 %	9.25 %	9.04 %	8.97 %
BIIB's Total Ranking	# 1687	# 235	# 1350	# 1261	# 1339
Equity (TTM) in Millions	18,652	18,257	18,208	17,634	16,979
Seq. Equity Change	2.16 %	0.27 %	3.25 %	3.86 %	1.57 %
Seq. Net Income Change	-	-	-26.51 %	163.95 %	-9.82 %

Back to BIIB Management Effectiveness >> BIIB's 5 Years Annual ROE >> Compare BIIB ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 13
Sector	# 158
Overall	# 1687

Return On Equity Statistics
High	Average	Low
46.79 %	20.53 %	0.5 %
(Jun 30 2020)		(June 30. 2006)

BIIB Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Equity in Millions	18,257	16,716	14,799	13,388	10,960
Y / Y Equity Change	9.22 %	12.95 %	10.54 %	22.16 %	2.56 %
Net Income in Millions	1,293	1,632	1,162	2,962	1,728
Y / Y Net Income Change	-20.79 %	40.53 %	-60.78 %	71.43 %	-57.45 %
Return On Equity	7.08 %	9.76 %	7.85 %	22.12 %	15.76 %

Back to BIIB Management Effectiveness >> BIIB's 5 Years Annual ROE >> Compare BIIB ROE to its Competitors

Annual Roe Comment

In 2025 ROE decreased compared to the previous year to 7.08 %, due to deterioration of net income.

More Return On Equity Ratios
Biotechnology & Pharmaceuticals Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
BIIB's' Return on Equity at Yahoo Finance
BIIB's Roe Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for BIIB's Competitors
Subscribers only: Roe for Biogen Inc 's Suppliers
Subscribers only: Return On Equity for BIIB's Customers

Companies with similar Return On Equity at Mar 31 2026, within Healthcare Sector	ROE
Teva Pharmaceutical Industries Limited	20.74 %
Exagen Inc	20.63 %
Sotera Health Company	20.57 %
Puma Biotechnology Inc	20.37 %
Pediatrix Medical Group Inc	20.09 %
Ge Healthcare Technologies Inc	19.37 %
Krystal Biotech Inc	19.25 %
United Therapeutics Corporation	19.24 %
Ani Pharmaceuticals Inc	18.02 %
Inspire Medical Systems inc	17.98 %
Merck and Co Inc	17.91 %
West Pharmaceutical Services Inc	17.87 %
Strata Critical Medical Inc	17.55 %
Standard Biotools Inc	17.29 %
Harmony Biosciences Holdings inc	17.19 %
Profound Medical Corp	17.12 %
Intuitive Surgical Inc	17.01 %
Lifevantage Corp	16.95 %
Brightspring Health Services Inc	16.65 %
Ensign Group Inc	16.63 %
Ufp Technologies Inc	16.61 %
Medinotec Inc	16.56 %
Ligand Pharmaceuticals Incorporated	16.19 %
Lemaitre Vascular Inc	16.19 %
Sbc Medical Group Holdings Incorporated	15.93 %
Bioventus Inc	15.86 %
Cryoport inc	15.28 %
Option Care Health Inc	15.28 %
Stryker Corp	15.10 %
Kewaunee Scientific Corporation	14.95 %

Date modified: 2026-09-26T07:00:31+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.